Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy

Author(s):: Breemen, M.J. van; Rombach, S.M.; Dekker, N.; Poorthuis, B.J.; Linthorst, G.E.; Zwinderman, A.H.; Breunig, F.; Wanner, C.; Aerts, J.M.F.G. (0000-0001-8168-2565); Hollak, C.E.

Published: 2011
Publication type: Article / Letter to editor

Fabry diseaseGlobotriaosylsphingosine, LysoGb3Enzyme replacement therapy (ERT)

Date issued: 2011-01-31
Language: English
Is part of: Biochimica et Biophysica Acta: Molecular Basis of Disease (2011), Vol. 1812, no. 1, p. 70-76
hdl: 1887/61932
doi: 10.1016/j.bbadis.2010.09.007
URL: https://www.sciencedirect.com/science/article/pii/S0925443910002073?via=ihub